Chenran Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Epidemiology top 10%
- Autophagy in Disease and Therapy
Papers in
-
- Protein Structure and Dynamics 3
- Glycosylation and Glycoproteins Research 2
- Epigenetics and DNA Methylation 2
- Oncology 3
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Wen‐Cai Ye (9 shared papers)Dongmei Zhang (8 shared papers)Zhe‐Sheng Chen (5 shared papers)Nan Yao (4 shared papers)Yingjie Li (3 shared papers)Nan Hu (2 shared papers)Yuhe Lei (2 shared papers)Minfeng Chen (3 shared papers)
- Journals
- Drug Resistance Updates (2 papers)Signal Transduction and Targeted Therapy (1 paper)Chinese Journal of Cancer (1 paper)Frontiers in Environmental Science (1 paper)International Journal of Biological Sciences (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Chenran Wang
18 papers receiving 1.1k citations
Chenran Wang's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 223
- Epidemiology 280
- Molecular Biology 585
- Geriatrics and Gerontology 27
- Oncology 188
Countries citing papers authored by Chenran Wang
This map shows the geographic impact of Chenran Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenran Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenran Wang more than expected).
Fields of papers citing papers by Chenran Wang
This network shows the impact of papers produced by Chenran Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenran Wang. The network helps show where Chenran Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenran Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Autophagy and multidrug resistance in cancer Hit paper breakdown → | 2017 | 565 |
| 2 | 2019 | 123 | |
| 3 | 2022 | 110 | |
| 4 | 2022 | 92 | |
| 5 | 2020 | 82 | |
| 6 | 2019 | 40 | |
| 7 | 2015 | 38 | |
| 8 | 2020 | 35 | |
| 9 | 2022 | 13 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 1 |
About Chenran Wang
Chenran Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Computational Theory and Mathematics, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Protein Structure and Dynamics (3 papers), Glycosylation and Glycoproteins Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Computational Drug Discovery Methods (2 papers), Epigenetics and DNA Methylation (2 papers), Autophagy in Disease and Therapy (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (223 citations), Epidemiology (280 citations), Molecular Biology (585 citations), Geriatrics and Gerontology (27 citations) and Oncology (188 citations). Chenran Wang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Wen‐Cai Ye, Dongmei Zhang, Zhe‐Sheng Chen, Nan Yao, Yingjie Li, Nan Hu, Yuhe Lei, Minfeng Chen, Lijuan Deng and Maohua Huang. Their work appears in journals such as Drug Resistance Updates, Signal Transduction and Targeted Therapy, Chinese Journal of Cancer, Frontiers in Environmental Science and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.